Effects of long-term strontium ranelate treatment on vertebral fracture risk in postmenopausal women with osteoporosis

SUMMARY: Vertebral fractures are a major adverse consequence of osteoporosis. In a large placebo-controlled trial in postmenopausal women with osteoporosis, strontium ranelate reduced vertebral fracture risk by 33% over 4 years, confirming the role of strontium ranelate as an effective long-term tre...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Meunier, P. J., Roux, C., Ortolani, S., Diaz-Curiel, M., Compston, J., Marquis, P., Cormier, C., Isaia, G., Badurski, J., Wark, J. D., Collette, J., Reginster, J. Y.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Springer-Verlag 2009
Aiheet:
Original Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC2744775/
https://ncbi.nlm.nih.gov/pubmed/19153678
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00198-008-0825-6
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia